ESR1 and breast cancer: When luminal CD24+ ERα+TP53mut breast cancer cells are cultured under long-term estrogen deprivation, they transition into a “reprogrammed” CD44+ ERα− basal-like phenotype resistant to antiestrogen therapy (79).